Exploring the protective role of GDF5 against skeletal muscle disuse atrophy - Institut de Biologie François JACOB Access content directly
Conference Poster Year : 2022

Exploring the protective role of GDF5 against skeletal muscle disuse atrophy


Skeletal muscle is a high plastic tissue able to change its mass upon different stimuli accordingly with environmental changes. Its adaptability depends on many factors and is based on complex mechanisms. Among the process that could alter muscle mass homeostasis, disuse and inactivity induce strong muscle mass and function decrease, having heavy impact on life quality and requiring long time to recover. Growth Differentiation Factor 5 (GDF5) is a crucial player in muscle homeostasis, shown to counteract both denervation- and age-related muscle wasting by limiting the activation of catabolic signals. However, its effects on disuse atrophy following muscle immobilization has to be investigated. In order to establish a potential therapeutic tool having a wide relevance, ranging from disease to microgravity exposure (space flight), we evaluated the consequences of GDF5 overexpression after 10 days of immobilization and 3 weeks of release of hind limb mouse muscles. We observed that local GDF5 overexpression in posterior limbs improved muscle mass loss during immobilization. However, three weeks after release, muscle mass and function were not affected by GDF5 overexpression. We aim to better characterize the effect of GDF5 treatment on several morphological and functional parameters of skeletal muscle upon immobilization/release. In addition, we will assess its eventual benefits at shorter time points after release, in order to establish if GDF5-based treatment could be proposed to shorten the time-window needed for optimal muscle recovery after disuse. In parallel, a study of microgravity exposure was carried on a muscle cell line. We showed that, in the absence of gravity, myotube formation was inhibited, suggesting that this condition could impact cytoskeleton and fusion capability. We will establish if GDF5 treatment might be beneficial for myoblast fusion and myotube morphology during microgravity exposure. In conclusion, our preliminary results suggest that a treatment based on GDF5 could have a therapeutic potential to ameliorate the pathophysiology of muscle during disuse condition to be applied also to space flight and microgravity exposure.
Fichier principal
Vignette du fichier
Poster Noviello Chiara Myologie2022 Nice.pdf (873.76 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-04020141 , version 1 (14-03-2023)


  • HAL Id : hal-04020141 , version 1


Chiara Noviello, Massiré Traoré, Bruno Cadot, Lucile Saillard, Béatrice Matot, et al.. Exploring the protective role of GDF5 against skeletal muscle disuse atrophy. Myology Conference 2022, Sep 2022, Nice (FRANCE), France. ⟨hal-04020141⟩
39 View
16 Download


Gmail Mastodon Facebook X LinkedIn More